Who
Sarah A. Teichmann
Director
Company insider
Files Form 4 as: Director, 10x Genomics.
In numbers
- Trades disclosed
- 10
- Buys
- 0
- Sells
- 3
- Bought
- $0
- Sold
- $1.2M
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 30 Aug 2024
- Last trade
- 14 Aug 2026
- Last filed
- 17 Aug 2026
Companies traded
Activity over time
1 Feb – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 Aug 2026filed 17 Aug 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $130K2,273 at $57.15 | filing |
| 14 Aug 2026filed 17 Aug 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $130K2,273 at $57.15 | filing |
| 13 Aug 2026filed 17 Aug 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $302K5,278 at $57.29 | filing |
| 13 Aug 2026filed 17 Aug 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $302K5,278 at $57.29 | filing |
| 4 Jun 2026filed 8 Jun 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Code A | —8,829 at $0.00 | filing |
| 4 Jun 2026filed 8 Jun 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Code A | —8,829 at $0.00 | filing |
| 25 Feb 2026filed 27 Feb 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $147K7,579 at $19.41 | filing |
| 25 Feb 2026filed 27 Feb 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $147K7,579 at $19.41 | filing |
| 3 Jun 2025filed 5 Jun 2025 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Code A | —15,357 at $0.00 | filing |
| 30 Aug 2024filed 4 Sep 2024 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Code A | —19,002 at $0.00 | filing |
News
7,724 Shares in 10x Genomics $TXG Bought by QP Wealth Management LLCTXG · dailypolitical.com · 21 Oct 2026
0 headlines in the last 90 days name Sarah A. Teichmann; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.